Tamoxifen [orch, phsu]
Prevention [topp]
Breast Cancer [neop]
Current [tmco]
Status [qlco]
P NOS [aapp, imft]
Study [mnob]
Initial [tmco]
findings [ftcn]
Cancer Prevention Trial [resa]
P NOS [aapp, imft]
Tamoxifen [orch, phsu]
Reduced [qlco]
Estrogen receptor positive tumor [neop]
Osteoporotic Fractures [dsyn]
Women [popg]
Increased [qnco]
Breast Cancer [neop]
side effects [ftcn]
Clinical Significance [fndg]
Observed [ftcn]
Trial [resa]
Continued [idcn]
Report [inpr]
Update [tmco]
Initial [tmco]
findings [ftcn]
Methods [inpr]
Women [popg]
N NOS [aapp, imft]
Assigned [ftcn]
Receive [qlco]
placebo [topp]
Tamoxifen [orch, phsu]
Breast Cancer [neop]
Events [evnt]
Compared [acty]
Risk Ratios [qnco]
Confidence Intervals [qnco]
estimates [qnco]
Reticular [spco]
Benefit [qnco]
Tamoxifen [orch, phsu]
therapy [ftcn]
Compared [acty]
Age [orga]
Race [popg]
Categories [inpr]
Predicted [idcn]
Breast Cancer [neop]
Statistical Tests [inpr]
Side [spco]
Cumulative [qlco]
Invasive Breast Cancer [neop]
Reduced [qlco]
Women [popg]
placebo [topp]
Group [idcn]
Women [popg]
Tamoxifen [orch, phsu]
Group [idcn]
Cumulative [qlco]
Non-invasive [ftcn]
Breast Cancer [neop]
Reduced [qlco]
Women [popg]
placebo [topp]
Group [idcn]
Women [popg]
Tamoxifen [orch, phsu]
Group [idcn]
reductions [npop]
Seen [qlco]
Initial [tmco]
Report [inpr]
Tamoxifen [orch, phsu]
LED [mnob]
reduction [npop]
Osteoporotic Fractures [dsyn]
Risks, Relative [qnco]
Stroke [dsyn]
Deep Vein Thrombosis [dsyn]
Cataracts [anab]
Increased [qnco]
Tamoxifen [orch, phsu]
ischaemic heart disease [dsyn]
Changed [ftcn]
Tamoxifen [orch, phsu]
Initially [tmco]
Reported [inpr]
Risks [qlco]
Pulmonary Embolism [dsyn]
Approximately [qlco]
Original report [inpr]
Endometrial Cancer [neop]
Not significant [fndg]
Statistically [ocdi]
Reticular [spco]
Benefit [qnco]
Tamoxifen [orch, phsu]
Age [orga]
Race [popg]
Breast Cancer [neop]
Conclusions [idcn]
Bias [idcn]
P NOS [aapp, imft]
Trial [resa]
Magnitudes [qnco]
undesirable effects [ftcn]
treatment [ftcn]
Tamoxifen [orch, phsu]
Initially [tmco]
Reported [inpr]
reductions [npop]
Breast Cancer [neop]
Increased [qnco]
Thromboembolic events [patf]
Endometrial Cancer [neop]
Identifiable [qlco]
Subset [clas]
2 5 [qnco]
Million [qnco]
Women [popg]
Reticular [spco]
Benefit [qnco]
Drug [phsu]
